Alternating Mitomycin C and BCG Instillations versus BCG Alone in Treatment of Carcinoma in Situ of the Urinary Bladder: A Nordic Study
- 1 June 2003
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 43 (6) , 637-645
- https://doi.org/10.1016/s0302-2838(03)00140-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical TrialsJournal of Urology, 2002
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- Results of a European Comparative Randomized Study Comparing Oral Bropirimine versus Intravesical BCG Treatment in BCG-Naive Patients with Carcinoma in situ of the Urinary BladderEuropean Urology, 1999
- The Treated Natural History of High Risk Superficial Bladder Cancer: 15-year OutcomeJournal of Urology, 1997
- Alternating Mitomycin C and Bacillus Calmette-Guerin Instillation Therapy for Carcinoma in Situ of the BladderJournal of Urology, 1995
- Urothelial Atypia Concomitant with Primary Bladder TumourScandinavian Journal of Urology and Nephrology, 1987
- UROTHELIAL DYSPLASIA CONCOMITANT WITH BLADDER TUMOURS AS A DETERMINANT FACTOR FOR FUTURE NEW OCCURRENCESThe Lancet, 1983
- Tables of the number of patients required in clinical trials using the logrank testStatistics in Medicine, 1982
- Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and ToxicityPublished by Wolters Kluwer Health
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958